Report 26 Jan 2011

Improving access to medicines for non-communicable diseases in the developing world

Read more
Report 26 Jan 2011

WHPA health improvement card

Read more
Report 26 Jan 2011

A shared commitment to fight non-communicable disease

Read more
Report 26 Jan 2011

Data exclusivity: Encouraging development of new medicines

Read more
Report 26 Jan 2011

Population attitude to personal health: perception of health, understanding of risk factors, morbidity and mortality

Read more
Press release 10 Nov 2010

IFPMA announces Amgen as new member company

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Amgen has become its newest member company. IFPMA Director General Eduardo Pisani said: “Amgen is a major force in the increasingly significant biotech sector and is therefore an important and welcome addition to the IFPMA. Amgen will provide us with new...

Read more
Press release 10 Nov 2010

IFPMA companies undertaking 100+ R&D projects for diseases of the developing world

R&D Partnerships Exemplify IFPMA Assembly Theme “A Shared Commitment to Global Health” The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has just published the 2010 edition of its Status Report on Pharmaceutical Industry R&D for Diseases of the Developing World(1). The report highlights the increasing efforts of IFPMA member companies(2), working with partners or...

Read more
Press release 10 Nov 2010

Mr. David Brennan of AstraZeneca elected president of IFPMA

New Vice Presidents are Mr. John Lechleiter of Lilly and Mr. Masafumi Nogimori of Astellas  The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Mr. David Brennan, Chief Executive Officer of AstraZeneca has been elected IFPMA President. Mr. Brennan succeeds outgoing IFPMA President Mr. Haruo Naito, President and CEO of...

Read more
Press release 10 Nov 2010

25th IFPMA assembly explores theme of “A shared commitment to global health”

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) held its 25 th Assembly today in Washington DC, USA. This biannual event brought together CEOs and senior figures from IFPMA member companies and associations. They were joined by senior figures from intergovernmental organizations, national governments, the Washington diplomatic community and health-related NGOs. IFPMA Director General,...

Read more
Statement 12 Oct 2010

WIPO standing committee on the law of patents

IFPMA Statement to the WIPO Standing Committee on the Law of Patents (SCP) Remarks by Mr. Andrew Jenner, Director, Intellectual Property & Trade, IFPMA  Mr. Chairman The International Federation of Pharmaceutical Manufactures and Associations (IFPMA) would like to thank you for the opportunity to input on the important discussions within the SCP. The IFPMA represents...

Read more
Press release 17 Sep 2010

Research-based pharmaceutical industry aid to Pakistan amounts to more than USD 3.3 million

The research-based pharmaceutical industry represented by the IFPMA is providing emergency aid to assist Pakistan in coping with the health consequences of the extensive flooding it is experiencing. The total value of assistance provided so far by IFPMA member companies*, including both cash and donation of medicines and other medical supplies, amounts to USD 3.33...

Read more
Press release 16 Sep 2010

IFPMA President calls on industry to continue MDG contributions beyond 2015

The United Nations Summit on the Millennium Development Goals on 20-22 September will review progress and look at ways of accelerating progress. The UN’s 2010 MDG Report indicates that the goals are achievable, despite uneven progress, and exhorts everyone to try to keep the promise of the Millennium Declaration. Mr. Haruo Naito, President of the...

Read more